Expansion of human bone marrow-derived mesenchymal stromal cells with enhanced immunomodulatory properties
Abstract Background Mesenchymal stromal cells (MSCs) have broad potential as a cell therapy including for the treatment of drug-resistant inflammatory conditions with abnormal T cell proliferation such as graft-versus-host disease (GVHD). Clinical su...
Main Authors: | , , , , , , , , , , , |
---|---|
Other Authors: | |
Format: | Article |
Language: | English |
Published: |
BioMed Central
2023
|
Online Access: | https://hdl.handle.net/1721.1/152384 |